News
0
NovAliX, a drug discovery-focused contract research organisation, and Chemical.AI, an artificial intelligence (AI) company, have announced a...
0
The FDA has approved Exelixis’ Cabometyx (cabozantinib) for patients with advanced renal cell carcinoma (RCC) as a first-line treatment in...
0
Digital health platform Curelator has announced new data that shows a lack of association between increased stress and migraine attacks.
0
Genentech has announced positive top-line results from two identically designed global Phase III studies, TENAYA and LUCERNE, evaluating its...
Features
In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas of the cancer drugs...
Featured Appointment
Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer.
As a key member...
Service Company News
Featured Event
11/01/2021 - 15/01/2021 -
Virtual Event,
@Pharmafocus
